Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Pallisgaard

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecanKaren-Lise Garm Spindler, Niels Pallisgaard, Ivan Vogelius, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosisThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2008
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
BMC Cancer|January 24, 2008
Identification of genes for normalization of real-time RT-PCR data in breast carcinomasMaria B Lyng, Anne-Vibeke Laenkholm, Niels Pallisgaard, et al.
British Journal of Haematology|February 23, 2007
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disordersThomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch, et al.
International Journal of Cancer|March 25, 2014
Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasmaKaren-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2015
Controls to validate plasma samples for cell free DNA quantificationNiels Pallisgaard, Karen-Lise Garm Spindler, Rikke Fredslund Andersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Improved sensitivity of circulating tumor DNA measurement using short PCR ampliconsRikke Fredslund Andersen, Karen-Lise Garm Spindler, Ivan Brandslund, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecanKaren-Lise Garm Spindler, Niels Pallisgaard, Ivan Vogelius, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosisThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2008
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
BMC Cancer|January 24, 2008
Identification of genes for normalization of real-time RT-PCR data in breast carcinomasMaria B Lyng, Anne-Vibeke Laenkholm, Niels Pallisgaard, et al.
British Journal of Haematology|February 23, 2007
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disordersThomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch, et al.
International Journal of Cancer|March 25, 2014
Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasmaKaren-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2015
Controls to validate plasma samples for cell free DNA quantificationNiels Pallisgaard, Karen-Lise Garm Spindler, Rikke Fredslund Andersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Improved sensitivity of circulating tumor DNA measurement using short PCR ampliconsRikke Fredslund Andersen, Karen-Lise Garm Spindler, Ivan Brandslund, et al.
Pageof 7